Intellego CEO Detained for Fraud; Nasdaq Delisting Sought, Reports Medtech Magazine
Photo by Jonathan Gong on Unsplash
Claes Lindahl, Intellego Technologies' ex-CEO, has been detained due to heightened suspicion of aggravated fraud, according to a Stockholm District Court ruling. The investigation, led by State Prosecutor Thomas Hertz, is scrutinizing Intellego's public communications since 2025 to ascertain if investors were intentionally misled regarding the company's market value. Nasdaq is also in the process of delisting Intellego Technologies from the First North exchange.
Key takeaways
- According to *Medtech Magazine*, Claes Lindahl, the former CEO of Intellego Technologies, has been detained based on a Stockholm District Court ruling, citing increased suspicion of aggravated fraud
- The ongoing investigation centers on the company's public statements, specifically reviewing press releases and quarterly reports dating back to 2025
- State Prosecutor Thomas Hertz stated that the investigation aims to determine if Intellego Technologies, through its representatives, intentionally misled investors to artificially inflate the company's market valuation
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.